Insider Transactions Reported by 17 Insiders of PDS Biotechnology Corp

Symbol: PDSB on Nasdaq
Location: Princeton, NJ

Quick Takeaways

PDSB - PDS Biotechnology Corp has 17 insiders with reported activity on this page.
No net insider buy/sell flow is currently reported for the last year.
Recent transaction rows are available for direct filing-level review.

What Changed

No meaningful buy/sell imbalance is currently visible in the one-year window.
Activity will update as new Forms 3/4/5 are filed.

Why This Matters

This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.

Official SEC Source

Filed on Form 4

Issuer insider activity is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Insider trading overview

Last 12 months

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 09 Apr 2025.

Buys

Shares: 0

Insiders: 0

Sells

Shares: 0

Insiders: 0

Net

Shares: 0

Insiders: 0

Window (months)	Buy $	Sell $	Net $
0-3	$0	$0	$0
3-6	$0	$0	$0
6-9	$0	$0	$0
9-12	$0	$0	$0

PDS Biotechnology Corp executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Valuation	Report Date
DeLyle W. Bloomquist	Resigned as a Director on June 17, 2021.	$7,813,350	Mixed	16 Jun 2021
Seth van Voorhees	Chief Financial Officer	$172,588	Mixed	15 Jun 2021
Stephen C. Glover	Director	$130,893	Filing P/S	12 Jan 2026
Gregory Gene Freitag	Director	$101,614	Filing P/S	12 Jan 2026
Dr. Otis W. Brawley	Director		Mixed	12 Jan 2026
Ilian Iliev	Director		Mixed	12 Jan 2026
Richard Sykes	Director		Mixed	24 Jun 2024
Lars Boesgaard	Chief Financial Officer		Mixed	12 Jan 2026
Frank Bedu-Addo	President/CEO, Director		Mixed	12 Jan 2026
Janetta Trochimiuk	Principal Accounting Officer		Mixed	30 Sep 2021
Kamil Ali-Jackson	Director		Mixed	12 Jan 2026
Stephan Toutain	Chief Operating Officer		Mixed	12 Jan 2026
Kirk V Shepard	Chief Medical Officer		Mixed	12 Jan 2026
Gregory Conn	Chief Scientific Officer		Mixed	12 Jan 2026
Matthew C. Hill	Chief Financial Officer		Mixed	05 Jan 2023
Lauren Wood	Chief Medical Officer		Mixed	05 Jan 2023
Spencer D. Brown	Senior VP, General Counsel		Mixed	12 Jan 2026

Top shareholders of PDS Biotechnology Corp (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
DeLyle W. Bloomquist	3/4/5	Resigned as a Director on June 17, 2021.	— mixed-class rows	804,941 mixed-class rows	$7,813,350	—	16 Jun 2021	3/4/5
ARMISTICE CAPITAL, LLC	13F	Company	5.7%	2,834,506	$2,182,003	—	31 Dec 2025	13F
VANGUARD GROUP INC	13F	Company	3.9%	1,950,946	$1,502,228	—	31 Dec 2025	13F
BlackRock, Inc.	13F	Company	1.1%	522,211	$401,998	—	31 Dec 2025	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1%	520,398	$400,666	—	31 Dec 2025	13F
UBS Group AG	13F	Company	0.51%	251,705	$193,812	—	31 Dec 2025	13F
BLAIR WILLIAM & CO/IL	13F	Company	0.5%	250,000	$192,450	—	31 Dec 2025	13F
Seth van Voorhees	3/4/5	Chief Financial Officer	— class O/S missing	17,647	$172,588	—	15 Jun 2021	3/4/5
COMMONWEALTH EQUITY SERVICES, LLC	13F	Company	0.4%	196,797	$151,490	—	31 Dec 2025	13F
Squarepoint Ops LLC	13F	Company	0.39%	192,556	$148,230	—	31 Dec 2025	13F
INSPIRION WEALTH ADVISORS, LLC	13F	Company	0.36%	180,495	$138,945	—	31 Dec 2025	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.36%	176,700	$136,024	—	31 Dec 2025	13F
Stephen C. Glover	3/4/5	Director	— mixed-class rows	148,788 mixed-class rows	$130,893	—	12 Jan 2026	3/4/5
NORTHERN TRUST CORP	13F	Company	0.29%	143,873	$110,753	—	31 Dec 2025	13F
STATE STREET CORP	13F	Company	0.27%	133,333	$102,640	—	31 Dec 2025	13F
Gregory Gene Freitag	3/4/5	Director	— mixed-class rows	131,149 mixed-class rows	$101,614	—	12 Jan 2026	3/4/5
Iron Gate Global Advisors LLC	13F	Company	0.15%	75,016	$57,747	—	31 Dec 2025	13F
Bank of New York Mellon Corp	13F	Company	0.14%	69,311	$53,356	—	31 Dec 2025	13F
Tempus Wealth Planning, LLC	13F	Company	0.12%	61,800	$47,574	—	31 Dec 2025	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.08%	38,566	$29,688	—	31 Dec 2025	13F
XTX Topco Ltd	13F	Company	0.07%	34,218	$26,341	—	31 Dec 2025	13F
Virtu Financial LLC	13F	Company	0.06%	32,099	$25,000	—	31 Dec 2025	13F
ACT CAPITAL MANAGEMENT, LLC	13F	Company	0.06%	30,000	$23,094	—	31 Dec 2025	13F
Rockefeller Capital Management L.P.	13F	Company	0.05%	25,664	$19,756	—	31 Dec 2025	13F
SIMPLEX TRADING, LLC	13F	Company	0.04%	19,106	$14,711	—	31 Dec 2025	13F
StoneX Group Inc.	13F	Company	0.03%	16,000	$12,317	—	31 Dec 2025	13F
FIRST MANHATTAN CO. LLC.	13F	Company	0.03%	15,000	$11,547	—	31 Dec 2025	13F
Federation Des Caisses Desjardins du Quebec	13F	Individual	0.03%	14,800	$11,396	—	31 Dec 2025	13F
Ground Swell Capital, LLC	13F	Company	0.03%	14,703	$11,318	—	31 Dec 2025	13F
RAYMOND JAMES FINANCIAL INC	13F	Company	0.03%	13,736	$10,574	—	31 Dec 2025	13F
Wealth Group, Ltd.	13F	Company	0.03%	13,399	$10,000	—	31 Dec 2025	13F
DAVENPORT & Co LLC	13F	Company	0.02%	10,000	$7,698	—	31 Dec 2025	13F
GRANDFIELD & DODD, LLC	13F	Company	0.02%	10,000	$7,698	—	31 Dec 2025	13F
CITIGROUP INC	13F	Company	0.02%	9,393	$7,231	—	31 Dec 2025	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.01%	5,329	$4,102	—	31 Dec 2025	13F
MORGAN STANLEY	13F	Company	0.01%	4,922	$3,789	—	31 Dec 2025	13F
GROUP ONE TRADING LLC	13F	Company	0.01%	3,922	$3,019	—	31 Dec 2025	13F
CREATIVE FINANCIAL DESIGNS INC /ADV	13F	Company	0.01%	3,000	$2,309	—	31 Dec 2025	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	2,220	$1,709	—	31 Dec 2025	13F
JONES FINANCIAL COMPANIES LLLP	13F	Company	0%	2,000	$1,538	—	31 Dec 2025	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	1,028	$791	—	31 Dec 2025	13F
Truvestments Capital LLC	13F	Company	0%	655	$504	—	31 Dec 2025	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0%	648	$499	—	31 Dec 2025	13F
SBI Securities Co., Ltd.	13F	Company	0%	109	$84	—	31 Dec 2025	13F
JPMORGAN CHASE & CO	13F	Company	0%	19	$15	—	31 Dec 2025	13F
OSAIC HOLDINGS, INC.	13F	Company	0%	17	$13	—	31 Dec 2025	13F
Frank Bedu-Addo	3/4/5	President/CEO, Director	— class O/S missing	548,782	—	—	12 Jan 2026	3/4/5
Kirk V Shepard	3/4/5	Chief Medical Officer	— class O/S missing	300,000	—	—	12 Jan 2026	3/4/5
Lars Boesgaard	3/4/5	Chief Financial Officer	— class O/S missing	300,000	—	—	12 Jan 2026	3/4/5
Spencer D. Brown	3/4/5	Senior VP, General Counsel	— class O/S missing	300,000	—	—	12 Jan 2026	3/4/5

Recent Insider Transactions by Companies or Individuals for PDS Biotechnology Corp

Showing up to 300 most recent insider transactions from the last 12 months.

Insider	Symbol	Class	Transaction	Shares	Shares Owned	Date	Ownership
Frank Bedu-Addo	PDSB	Employee Stock Option (Right to Buy)	Award	548,782	548,782	12 Jan 2026	Direct
Gregory Conn	PDSB	Employee Stock Option (Right to Buy)	Award	150,000	150,000	12 Jan 2026	Direct
Kirk V Shepard	PDSB	Employee Stock Option (Right to Buy)	Award	300,000	300,000	12 Jan 2026	Direct
Lars Boesgaard	PDSB	Employee Stock Option (Right to Buy)	Award	300,000	300,000	12 Jan 2026	Direct
Spencer D. Brown	PDSB	Employee Stock Option (Right to Buy)	Award	300,000	300,000	12 Jan 2026	Direct
Stephan Toutain	PDSB	Employee Stock Option (Right to Buy)	Award	300,000	300,000	12 Jan 2026	Direct
Gregory Gene Freitag	PDSB	Employee Stock Option (Right to Buy)	Award	54,876	54,876	12 Jan 2026	Direct
Ilian Iliev	PDSB	Employee Stock Option (Right to Buy)	Award	54,876	54,876	12 Jan 2026	Direct
Kamil Ali-Jackson	PDSB	Employee Stock Option (Right to Buy)	Award	54,876	54,876	12 Jan 2026	Direct
Otis W. Brawley	PDSB	Employee Stock Option (Right to Buy)	Award	54,876	54,876	12 Jan 2026	Direct
Stephen C. Glover	PDSB	Employee Stock Option (Right to Buy)	Award	54,876	54,876	12 Jan 2026	Direct
Frank Bedu-Addo	PDSB	Employee Stock Option (Right to Buy)	Award	150,000	150,000	12 Jun 2025	Direct
Kirk V Shepard	PDSB	Employee Stock Option (Right to Buy)	Award	150,000	150,000	12 Jun 2025	Direct
Spencer D. Brown	PDSB	Employee Stock Option (Right to Buy)	Award	150,000	150,000	12 Jun 2025	Direct
Lars Boesgaard	PDSB	Employee Stock Option (Right to Buy)	Award	150,000	150,000	12 Jun 2025	Direct
Gregory Conn	PDSB	Employee Stock Option (Right to Buy)	Award	40,000	40,000	12 Jun 2025	Direct
Stephan Toutain	PDSB	Employee Stock Option (Right to Buy)	Award	150,000	150,000	12 Jun 2025	Direct
Otis W. Brawley	PDSB	Employee Stock Option (Right to Buy)	Award	22,700	22,700	11 Jun 2025	Direct
Kamil Ali-Jackson	PDSB	Employee Stock Option (Right to Buy)	Award	22,700	22,700	11 Jun 2025	Direct
Ilian Iliev	PDSB	Employee Stock Option (Right to Buy)	Award	22,700	22,700	11 Jun 2025	Direct
Gregory Gene Freitag	PDSB	Employee Stock Option (Right to Buy)	Award	22,700	22,700	11 Jun 2025	Direct
Stephen C. Glover	PDSB	Employee Stock Option (Right to Buy)	Award	22,700	22,700	11 Jun 2025	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.